This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Lactic Acid in the Rectum and Life-Threatening Infection

This study has been completed.
Information provided by:
Herlev Hospital Identifier:
First received: September 14, 2005
Last updated: June 5, 2009
Last verified: June 2009

Life-threatening infection impairs bloodflow to the gut, thereby causing less delivery of oxygen. This leads to increased formation of lactic acid.

The investigators hypothesize, that the more serious the condition, the higher the concentration of lactic acid will be, thus relating to the risk of multiple organ failure or death.

Condition Intervention
Septic Shock Procedure: Measurement of rectal lactic acid.

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Does the Concentration of L-Lactate in the Rectum Correlate With Mortality and Morbidity in Patients With Septic Shock?

Resource links provided by NLM:

Further study details as provided by Herlev Hospital:

Enrollment: 130
Study Start Date: November 2005
Study Completion Date: April 2009

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adult patients with early septic shock (< 24 h).

Inclusion Criteria:

  • Fluid resuscitated septic shock < 24 h.

Exclusion Criteria:

  • Septic shock > 24 h.
  • Pathology in the rectum.
  • Bleeding per rectum.
  • Limitation of therapy.
  • Where informed consent from relatives cannot be obtained.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00197938

Dept. of Intensive Care 4131, Rigshospitalet
Copenhagen, Denmark, DK-2100
Dept. of Intensive Care, Glostrup University Hospital
Glostrup, Denmark, DK-2600
Dept. of Intensive Care, Gentofte University Hospital
Hellerup, Denmark, DK-2900
Dept. of Intensive Care, Herlev University Hospital
Herlev, Denmark, DK-2730
Dept. of Intensive Care, Tampere University Hospital
Tampere, Finland, 33521
Sponsors and Collaborators
Herlev Hospital
Study Chair: Anders Perner, MD, PhD Dept. of Anaesthesia and Intensive Care, Herlev University Hospital, DK-2730 Herlev
  More Information

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00197938     History of Changes
Other Study ID Numbers: KA 05091m
Study First Received: September 14, 2005
Last Updated: June 5, 2009

Additional relevant MeSH terms:
Shock, Septic
Systemic Inflammatory Response Syndrome
Pathologic Processes
Shock processed this record on September 21, 2017